Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIDES: Azelaprag + Tirzepatide in Obesity
NCT06515418Phase 2Terminated
- Sponsor
- BioAge Labs
- Start
- Jun 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azelaprag in obesity, sponsored by BioAge Labs. Started Jun 2024; status: terminated.
02
Drugs
azelaprag
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06515418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06515418.